Lymphoid Neoplasm — Trials

Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

8,885 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,419
Recruiting: 1,268
Ph III recruiting: 131
Growth YoY: +6.7%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,373)

clinicaltrialsPublishedShowing 251–300 of 8,885 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05944562	Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome	active not recruiting	Phase 1	24	Washington University School of MedicineOTHER	1	Sep 16, 2026	clinicaltrials
NCT05949944	Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma	active not recruiting	Phase 1 / Phase 2	44	Sun Yat-sen UniversityOTHER	1	Sep 16, 2026	clinicaltrials